N-(3,4-dimethoxyphenyl)-O-phenyl carbamate | 65141-27-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(3,4-dimethoxyphenyl)-O-phenyl carbamate
• 英文别名: phenyl 3,4-dimethoxyphenylcarbamate；(3,4-dimethoxy-phenyl)-carbamic acid phenyl ester；(3,4-Dimethoxy-phenyl)-carbamidsaeure-phenylester；Phenyl N-(3,4-dimethoxyphenyl)carbamate
• CAS: 65141-27-7
• 化学式: C₁₅H₁₅NO₄
• 分子量: 273.288
• InChiKey: VNUDYKVPXJWTRV-UHFFFAOYSA-N

物化性质

• 沸点：
  376.3±42.0 °C(Predicted)
• 密度：
  1.228±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  56.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-(3,4-dimethoxyphenyl)-O-phenyl carbamate 在 一水合肼 、 溶剂黄146 作用下， 以 1,4-二氧六环 、 水 、 异丙醇 为溶剂， 生成 (E)-N⁴-(3,4-dimethoxyphenyl)-N¹-(3-fluoro-4-(6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yloxy)benzylidene)semicarbazide
  参考文献：
  名称：

  具有缩氨基脲支架作为选择性 c-Met 抑制剂的 4-苯氧基-6,7-二取代喹啉的合成和生物学评价

  摘要：

  制备了带有无环缩氨基脲的新型喹啉衍生物，并确定了它们的化学结构和相对立体化学。在体外评估了所有合成化合物的 c-Met 激酶抑制活性和对细胞系 HT-29、MKN-45 和 MDA-MB-231 的细胞毒性。针对 A549 细胞进一步评估了几种有效化合物。大多数化合物显示出中等至极好的活性，结构-活性关系研究确定了最有希望的化合物 35 作为选择性 c-Met 激酶抑制剂 (IC50 = 4.3 nM)。与 foretinib 相比，化合物 35 在体外对 HT-29 和 A549 细胞的细胞毒性分别增加了 3.5 倍和 18.8 倍。

  DOI：

  10.1002/ardp.201300087
• 作为产物：
  描述：

  氯甲酸苯酯 、 3,4-二甲氧基苯胺 以97%的产率得到N-(3,4-dimethoxyphenyl)-O-phenyl carbamate
  参考文献：
  名称：

  A Simple Method for the Preparation of Di-, Tri- and Tetrasubstituted Non-Symmetrical Ureas

  摘要：

  本文描述了一系列非对称二取代、三取代和四取代脲的合成。在自调谐单模微波合成器中，通过苯基氨基甲酸酯与伯胺或仲胺反应，可以高产率地制备二取代和三取代脲。合成上更具挑战性的四取代脲可以通过4-硝基苯基氨基甲酸酯和仲胺来制备。

  DOI：

  10.1055/s-2005-923584

文献信息

• Rhodium-Catalyzed Synthesis of Amides from Functionalized Blocked Isocyanates
  作者：Joshua S. Derasp、André M. Beauchemin

  DOI：10.1021/acscatal.9b02641

  日期：2019.9.6

  Isocyanates are useful building blocks for the synthesis of amides, although their widespread use has been limited by their high reactivity, which often results in poor functional group tolerance and a propensity to oligomerize. Herein, a rhodium-catalyzed synthesis of amides is described coupling boroxines with blocked (masked) isocyanates. The success of the reaction hinges on the ability to form

  异氰酸酯是酰胺合成的有用组成部分，尽管它们的广泛使用受到其高反应性的限制，这通常导致较差的官能团耐受性和低聚倾向。在本文中，描述了铑催化的酰胺的合成，其将环硼氧烷与封闭的（被掩蔽的）异氰酸酯偶联。反应的成功取决于原位形成异氰酸酯和有机铑中间体的能力。依赖于掩蔽的异氰酸酯前体和有机铑中间体的高反应性，可实现宽泛的官能团耐受性，包括质子亲核基团（如胺，苯胺和醇）。
• �berp-Methoxy- und 3, 4-Dimethoxyphenylurethane
  作者：Otto Brunner、Rolf W�hrl

  DOI：10.1007/bf01522231

  日期：1933.11
• Design, synthesis and biological evaluation of novel inosine 5′-monophosphate dehydrogenase (IMPDH) inhibitors
  作者：Torsten Dunkern、Sunil Chavan、Digambar Bankar、Anuja Patil、Pritee Kulkarni、Prashant S. Kharkar、Arati Prabhu、Heike Goebel、Edith Rolser、Waltraud Burckhard-Boer、Premkumar Arumugam、Mahindra T. Makhija

  DOI：10.3109/14756366.2013.793184

  日期：2014.6.1

  This study is based on our attempts to further explore the structure-activity relationship (SAR) of VX-148 (3) in an attempt to identify inosine 5'-mono-phosphate dehydrogenase (IMPDH) inhibitors superior to mycophenolic acid. A five-point pharmacophore developed using structurally diverse, known IMPDH inhibitors guided further design of novel analogs of 3. Several conventional as well as novel medicinal chemistry strategies were tried. The combined structure-and ligand-based approaches culminated in a few analogs with either retained or slightly higher potency. The compounds which retained the potency were also checked for their ability to inhibit human peripheral blood mononuclear cells proliferation. This study illuminates the stringent structural requirements and strict SAR for IMPDH II inhibition.
• Synthesis of N-aryl and N-arylcarbamoylamino derivatives of 1,3-diazinane-5-carboxamide and their activity against glioblastoma LN-229 cell line
  作者：Rebecca J. Hron、Branko S. Jursic、Donna M. Neumann

  DOI：10.1016/j.bmc.2016.09.074

  日期：2016.12

  Six structural motifs based on the initial (lead) structure of merbarone were designed, prepared, and tested against the glioblastoma LN-229 cell line. Three different structural moieties were modified in the search for optimal glioblastoma activity: the 1,3-diazinane moiety, the aryl moiety, and the heteroatom linker. Calculated molecular descriptors such as lipophilicity (ClogP), acidic strength (calculated pK(a)), and polar surface area (PSA) were used to design a diverse structural library of these compounds. From six different structural motifs and 136 compounds, a handful of examples with moderate (100 mu g/ml), good (10 mu g/ml) and excellent (1 mu g/ml) glioblastoma activity were elucidated. (C) 2016 Published by Elsevier Ltd.
• Synthesis and Biological Evaluation of 4-Phenoxy-6,7-disubstituted Quinolines Possessing Semicarbazone Scaffolds as Selective c-Met Inhibitors
  作者：Baohui Qi、Haiyan Tao、Di Wu、Jinying Bai、Yandan Shi、Ping Gong

  DOI：10.1002/ardp.201300087

  日期：2013.8

  Novel quinoline derivatives bearing acyclic semicarbazones were prepared and their chemical structures as well as the relative stereochemistry were confirmed. All the synthesized compounds were evaluated for their c‐Met kinase inhibitory activity and their cytotoxicity against the cell lines HT‐29, MKN‐45, and MDA‐MB‐231 in vitro. Several potent compounds were further evaluated against A549 cells.

  制备了带有无环缩氨基脲的新型喹啉衍生物，并确定了它们的化学结构和相对立体化学。在体外评估了所有合成化合物的 c-Met 激酶抑制活性和对细胞系 HT-29、MKN-45 和 MDA-MB-231 的细胞毒性。针对 A549 细胞进一步评估了几种有效化合物。大多数化合物显示出中等至极好的活性，结构-活性关系研究确定了最有希望的化合物 35 作为选择性 c-Met 激酶抑制剂 (IC50 = 4.3 nM)。与 foretinib 相比，化合物 35 在体外对 HT-29 和 A549 细胞的细胞毒性分别增加了 3.5 倍和 18.8 倍。